Latest Options News

Zenith Minerals has opened a fully underwritten $3.5 million entitlement offer, inviting shareholders to subscribe for new shares with free attaching options, aiming to bolster its gold and lithium exploration projects.

Macmahon Holdings has locked in a new $550 million syndicated debt facility, extending maturity to 2029 with improved terms and robust bank backing. This refinancing positions the company for strategic growth while maintaining a conservative liquidity stance.

Charter Hall Retail REIT has announced an ordinary unfranked dividend of AUD 0.124 per security for the six months ending 30 June 2025, with key dates set for late June and August.

QMines is set to complete its acquisition of the high-grade Mount Mackenzie Gold and Silver Project, boosting its resource base and planning a maiden drilling program to unlock further value.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

EV Resources appoints two seasoned mining executives to its board and secures AU$650,000 in placement funding to advance the restart of its Los Lirios Antimony Mine in Mexico, signaling a sharpened strategic focus.

NeuroScientific Biopharmaceuticals reveals compelling clinical evidence supporting its StemSmart MSC therapy for severe steroid-refractory graft versus host disease, advancing its strategic acquisition plans.

Dalaroo Metals has launched its maiden exploration program at the Blue Lagoon project in Greenland, targeting zirconium, niobium, and rare earth elements. Led by seasoned geologist Ole Christiansen, the program aims to validate promising historical geochemical anomalies and assess low-cost mining potential.

Meeka Metals has secured a $60 million institutional placement to fast-track gold production and expand drilling at its Murchison Gold Project in Western Australia, targeting first gold by June 2025.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

Amplia Therapeutics has announced a second confirmed complete response in its ACCENT trial for advanced pancreatic cancer, a notably rare achievement in this challenging disease.

HomeCo Daily Needs REIT has announced its ordinary quarterly distribution of AUD 0.02125 per unit, payable in August 2025, alongside a Dividend Reinvestment Plan offering investors a choice to reinvest without discount.